Sponsor Pipeline

Eloxx Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07523581 EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren… Alport Syndrome, X-Linked Recruiting
Get alerts when Eloxx Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free